Sutro Biopharma Inc buy Wells Fargo & Company
Start price
24.03.26
/
50%
€0.62
Target price
24.03.27
€23.30
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.03.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Sutro Biopharma Inc | - |
| iShares Core DAX® | -3.509% |
| iShares Nasdaq 100 | -2.782% |
| iShares Nikkei 225® | -2.038% |
| iShares S&P 500 | -2.598% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma (STRO) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $27.00 price target on the stock, up from $8.00.
Ratings data for STRO provided by MarketBeat